Elsevier Acquires QUOSA, Provider of Life Sciences Content Management and Workflow Productivity Solutions

Acquisition enhances Elsevier’s ability to help researchers and information professionals improve their search, retrieval and content management efficiency

Amsterdam, January 12, 2012 - Elsevier, the world-leading provider of scientific, technical, and medical information products and services, announced today the acquisition of QUOSA a content management and workflow productivity solutions provider for researchers and information managers.

QUOSA’s current solutions and platform, including its Information Manager and Virtual Library, will continue to be supported. QUOSA’s technological capabilities will be developed into Elsevier-branded solutions, raising the efficiency of the search and discovery process. They will also allow researchers and information professionals to manage information more efficiently at the various stages of the research workflow including organizing, archiving and sharing. 

“Elsevier is focused on delivering productivity enhancing tools to researchers and information managers to help accelerate and promote scientific discovery. Our acquisition of QUOSA ensures that we continue to deliver more value to our customers by improving the search, retrieval, management, analysis and sharing of the increasingly disparate types of information required to improve research outcomes,” said Alexander van Boetzelaer, Managing Director of Elsevier Corporate Markets. “QUOSA brings to Elsevier an innovative offering and technological expertise that align well with Elsevier today.”

Elsevier and QUOSA have collaborated successfully since 2007 when the latter’s PDF Download Manager was incorporated in SciVerse Scopus. Later the feature was embedded in SciVerse ScienceDirect. Elsevier’s acquisition of QUOSA marks a continuation of this collaboration which has boosted research productivity for the users of both solutions. 

“QUOSA empowers enterprises to share full-text scientific information faster and more efficiently, helping users to get more out of their information while controlling costs, all with one easy-to-use copyright observant solution,” said Malcolm MacKenzie, President and CEO, QUOSA. “Both our customers and the wider research community stand to benefit from the pooling of resources and expertise with Elsevier.” 

Founded in 1996 and headquartered in Boston, QUOSA began by targeting the academic and government segments and now also serves a range of corporate customers, including more than half of the Top 25 pharma-biotech companies. Financial details of the acquisition are not being disclosed. 

# # #

About QUOSA - The ONE Scientific Literature Solution
QUOSA Inc. is a specialist software company focused on literature management workflows and archives, which include full-text articles and patents. With a large and rapidly growing subscriber-base at leading universities, pharmaceutical, biotechnology and other life-science companies, and in other research and medical centers, QUOSA's applications are used to compress the time to insight and action across the key functions of the innovation enterprise. For more information about QUOSA, please visit the website at www.quosa.com.

About Elsevier

Elsevier is a world-leading provider of information solutions that enhance the performance of science, health, and technology professionals, empowering them to make better decisions, deliver better care, and sometimes make groundbreaking discoveries that advance the boundaries of knowledge and human progress. Elsevier provides web-based, digital solutions — among them ScienceDirect, Scopus, Elsevier Research Intelligence,and ClinicalKey—and publishes over 2,200 journals, including The Lancet and Cell, and over 25,000 book titles, including a number of iconic reference works.

The company is part of Reed Elsevier Group PLC, a world leading provider of professional information solutions in the Science, Medical, Legal and Risk and Business sectors, which is jointly owned by Reed Elsevier PLC and Reed Elsevier NV. The ticker symbols are REN (Euronext Amsterdam), REL (London Stock Exchange), RUK and ENL (New York Stock Exchange).

Media contact
Tom Reller
Vice President, Global Corporate Relations, Elsevier
+1 215 239 3508
t.reller@elsevier.com